BROOKE LONG: Open Payments
NPI 1558089813 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,209 in 117 payments from 24 companies in 2025. Trend: 2023 $1,864 · 2024 $2,292 · 2025 $2,209
Food & beverage: $2,209
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $347 |
| Novartis Pharmaceuticals Corporation | 13 | $279 |
| Neurocrine BioSciences, Inc. | 11 | $196 |
| Teva Pharmaceuticals USA, Inc. | 9 | $144 |
| ACADIA Pharmaceuticals Inc | 6 | $140 |
| Alexion Pharmaceuticals, Inc. | 6 | $139 |
| TG Therapeutics, Inc. | 5 | $109 |
| Genentech USA, Inc. | 4 | $101 |
| ARGENX US, INC. | 4 | $101 |
| UCB, Inc. | 3 | $90 |
Products named: KESIMPTA, UBRELVY, INGREZZA, AUSTEDO XR, NUPLAZID, ULTOMIRIS, BRIUMVI, VYVGART HYTRULO.
Industry payments across SC — which companies pay providers there.
